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Previous studies have shown that cortical stimulation selectively activates extracellular signal-regulated kinase 1/2 (ERK1/2) phosphor-
ylation and immediate early gene expression in striatal GABAergic enkephalinergic neurons. In the present study, we demonstrate that
blockade of adenosine A2A receptors with caffeine or a selective A2A receptor antagonist counteracts the striatal activation of cAMP–
protein kinase A cascade (phosphorylation of the Ser845 residue of the glutamate receptor 1 subunit of the AMPA receptor) andmitogen-
activated protein kinase (ERK1/2 phosphorylation) induced by the in vivo stimulation of corticostriatal afferents. The results indicate
that A2A receptors strongly modulate the efficacy of glutamatergic synapses on striatal enkephalinergic neurons.
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Introduction
The striatum is themain input and information processing struc-
ture of the basal ganglia. Cortico-limbic-thalamic glutamatergic
and mesencephalic dopaminergic systems converge in the
GABAergic medium-sized spiny neurons, which constitute
90% of the striatal neuronal population (Gerfen, 2004). These
are the striatal efferent neurons, which can be classified into
GABAergic enkephalinergic and GABAergic dynorphinergic
neurons. Enkephalinergic neurons predominantly express aden-
osine and dopamine receptors of the A2A andD2 subtype, respec-
tively, whereas dynorphinergic neurons predominantly express
adenosine and dopamine receptors of the A1 and D1 subtype,
respectively (Ferre´ et al., 1997, 2005; Gerfen, 2004).
The dopamine D1 receptor is a Gs/olf-coupled receptor, whose
main signaling pathway is the cAMP–protein kinase A (PKA)
cascade. The D1 receptor modulates neuronal excitability and
glutamatergic neurotransmission in the GABAergic dynorphin-
ergic neuron by inducing PKA-mediated phosphorylation of dif-
ferent substrates, such as L-type voltage-dependent calcium
channels, DARPP-32 (the dopamine and cyclic adenosine 3, 5-
monophosphate-regulated phosphoprotein, 32 kDa), the NMDA
and AMPA glutamate receptors (GluRs), and the nuclear consti-
tutive transcription factor cAMP response element binding pro-
tein (for review, see Greengard et al., 1999). Furthermore, the D1
receptor can potentially activate mitogen-activated protein ki-
nase (MAPK) [extracellular signal-regulated kinase 1/2 (ERK1/2)
phosphorylation] by PKA-dependent and -independent mecha-
nisms (Zanassi et al., 2001), which seem to require a concomitant
stimulation of NMDA receptors (Valjent et al., 2005).
The adenosine A2A receptor is functionally very similar to the
D1 receptor. It is also a Gs/olf-coupled receptor whose activation
stimulates the cAMP–PKA cascade. A2A receptor forms hetero-
mers with D2 receptor, which antagonistically modulates A2A re-
ceptor function by inhibiting adenylyl cyclase activation (Kull et
al., 1999; Hillion et al., 2002). Furthermore, stimulation of A2A
receptor decreases the ability of dopamine to bind theD2 receptor
by means of an intramembrane A2A–D2 receptor interaction
(Ferre´ et al., 1991). The same as with the D1 receptor, A2A
receptor-mediated PKA activation can potentially phosphorylate
different substrates and induce MAPK activation. However, un-
der basal conditions, there is a strong tonic activation of striatal
D2 receptors, which impairs the ability of A2A receptors to signal
through the cAMP–PKA cascade (for review, see Ferre´ et al.,
2004, 2005).
Both enkephalinergic and dynorphinergic neurons receive
corticostriatal afferents and display excitatory postsynaptic re-
sponses to corticostriatal stimulation (Kawaguchi et al., 1990).
Nevertheless, corticostriatal stimulation selectively activates
MAPK and immediate early gene (IEG) expression in the en-
kephalinergic neurons without activation in dynorphinergic
neurons (Berretta et al., 1997; Gerfen et al., 2002). In fact, MAPK
activation is responsible for the induction of striatal IEG expres-
sion after corticostriatal stimulation (Sgambato et al., 1998). In
the present study, we demonstrate that blockade of A2A receptors
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with caffeine or a selective A2A receptor antagonist counteracts
the striatal activation of cAMP–PKA cascade (phosphorylation of
the Ser845 residue of the GluR1 subunit of the AMPA receptor)
and MAPK (ERK1/2 phosphorylation) induced by the in vivo
stimulation of corticostriatal afferents. The results support our
hypothesis that strong cortico-limbic-thalamic input to the
GABAergic enkephalinergic neuron allows the A2A receptor to
override the inhibitory effects of the D2 receptor with significant
activation of the cAMP–PKA cascade and MAPK (Ferre´ et al.,
2004, 2005).
Materials andMethods
Electrical cortical stimulation. Male Sprague Dawley rats (250–300 g;
Charles River Laboratories, Wilmington, MA) were used in all experi-
ments. Animals weremaintained in accordancewith the guidelines of the
Institutional Care and Use Committee of the Intramural Research Pro-
gram, National Institute on Drug Abuse, National Institutes of Health.
The animals were implanted unilaterally under Equithesin (National In-
stitute on Drug Abuse Pharmacy, Baltimore, MD) anesthesia with bipo-
lar stainless steel electrodes, 0.15 mm in diameter (Plastics One,
Roanoke, VA), into the orofacial area of the lateral agranular motor
cortex (3 mm anterior, 3 mm lateral, and 4.2 mm below bregma). The
electrodes and a head holder (connected to a swivel during stimulation)
were fixed on the skull with stainless steel screws and dental acrylic resin.
Five days after surgery, rats were placed in individual bowl chambers, and
the implanted electrodes were attached to an electrical stimulator (Grass
S88K; Grass Instruments, West Warwick, RI). Ten minutes before corti-
cal stimulation, the animals were given an intraperitoneal administration
of saline, theA2A receptor antagonistMSX-3 (3,7-dihydro-8-[(1E)-2-(3-
methoxyphenyl)ethenyl]-7-methyl-3-[3-(phosphonooxy)propyl-1-(2-
propynyl)-1H-purine-2,6-dione]disodium salt hydrate) (3 mg/kg), the
A1 receptor antagonist 8-cyclopentyl-1,3-dimethylxanthine (CPT) (4.8
mg/kg), or the nonselective adenosine antagonist caffeine (anhydrate
base; 10 mg/kg). All drugs were purchased from Sigma (St. Louis, MO).
All drugs were dissolved in sterile saline (with a few drops of 0.1NNaOH
forMSX-3, final pH7.4) and administered in a volumeof 3ml/kg of body
weight. The doses of the adenosine antagonists were previously shown to
providemotor activation by selectively antagonizing A1 receptors (CPT),
A2A receptors (MSX-3), or both A1 and A2A receptors (caffeine) (Karcz-
Kubicha et al., 2003). The parameters of stimulation were the same as
those shownpreviously to induce selective phosphorylation of ERK1/2 in
enkephalinergic cells of the projecting striatal area, the lateral caudate–
putamen (Gerfen et al., 2002). After 10 min of habituation, biphasic
current pulse trains (pulse of 0.1 ms; 150–200A, 100 Hz, 160 ms trains
repeating once per second) were delivered using two coupled constant
current units (Grass PSIU6; Grass Instruments). The intensity was 150
A for most cases or it was increased up to 200 A, until small jaw
movements were observed. The cases that failed to show visible somatic
movements were excluded from additional analysis. In no case did ani-
mals display evidence of seizure activity from the electrical stimulation.
Stimulation was applied for 20 min, and the animals were killed imme-
diately after the stimulation offset.
Immunohistochemistry. Immediately after the offset of cortical stimu-
lation, rats were deeply anesthetized with Equithesin and perfused tran-
scardially with 0.1 M PBS, followed by 4% formaldehyde in 0.1 M sodium
phosphate monobasic buffer, pH 7.4. Brains were postfixed in the same
fixative for 2 h and immersed in 20% sucrose/0.1 M sodium phosphate,
pH 7.4, solution for 48 h at 4°C. Twenty-micrometer-thick coronal sec-
tions were cut at the anteroposterior (AP) level of bregma 0.0 1.0 mm
in a Leica (Nussloch, Germany)CM3050S cryostat at20°C, collected in
PBS, and stored in antifreeze-buffered solution (20% ethylene glycol,
10% glycerol, and 10% sucrose in PBS) at 80°C until processing. The
slices were then rinsed with PBS, incubated with 100 mM sodium boro-
hydride and 0.1% hydrogen peroxide in PBS for 10 min, rinsed, and
incubated in blocking buffer (PBS/0.1% Triton X-100/5% bovine serum
albumin) for 2 h before incubation with rabbit polyclonal anti-phospho-
Thr202/Tyr204 ERK1/2 (1:2000 dilution; Cell Signaling Technology, Dan-
vers, MA) in blocking buffer for 24 h at 4°C. Sections were washed and
incubated in 1:200 biotinylated goat anti-rabbit antibody (Vector Labo-
ratories, Burlingame, CA) for 2 h, then washed and incubated for 2 h in
ABC reagent (PK-6100; Vector Laboratories), washed again, treated with
0.33 mg/ml 3,3-diaminobenzidine, 50 mM ammonium nickel sulfate,
and 0.003% peroxide until development (5–10 min), transferred to PBS,
mounted onto chrom-alum gelatin-coated slides, air-dried, dehydrated
through graded ethanols, cleared in xylene, and coverslipped with DPX
(mixture of xylene and dibutyl phthalate; Fisher Scientific, Tustin, CA).
Images were acquired using a digital camera (HRC; Zeiss, Gottingen,
Germany) coupled to an Axioimager A1 microscope (Zeiss).
Western blotting. Immediately after the offset of cortical stimulation,
the animals were decapitated, and the brains were rapidly extracted,
frozen in dry ice-cold isopentane, and stored at 80°C. Subsequently,
unilateral tissue punches of the lateral striatum (16 gauge) at the AP level
of bregma 0.0, corresponding to the area with maximal expression of
phosphorylated ERK1/2 (Fig. 1), were obtained from 1 mm-thick
coronal sections cut in the cryostat at 20°C. The rostral side of the
coronal sections was localized approximately between bregma 0.5 mm
and bregma 0.5 mm. For Western blot assays, tissue punches were
sonicated for 10–15 s in sonication buffer (1% SDS in deionized sterile
water). The volume of sonication buffer was 200l. The protein concen-
trations of all samples were determined using a bicinchoninic acid assay
kit (Pierce, Rockford, IL) andwere further dilutedwith 1%SDS to equal-
ize the protein concentrations in each sample. Loading buffer (16% glyc-
erol, 20%mercaptoethanol, and 0.05%bromophenol blue) was added to
each sample (3:1, sample to loading buffer ratio) before heating at 95°C
for 10 min. The proteins in the samples were separated by SDS-PAGE
(10% acrylamide/0.27% N,N-methylenebisacryalamide resolving gel)
Figure 1. Striatal ERK1/2 phosphorylation induced by cortical electrical stimulation. A, D,
Immunohistochemical localization of phosphorylated ERK1/2 in coronal sections (AP level of
bregma 0.0) through the striatum ipsilateral to the implanted electrode from stimulated (A)
and sham nonstimulated (D) animals. B, C, E, F, Higher magnification of the respective fields
indicated in A and D, which shows cells displaying immunoreactivity to phospho-ERK1/2 anti-
body in the lateral caudate–putamen of the stimulated animals. Scale bars, 250m.
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for 3–4 h at 200 V. For each electrophoresis run, 20 l of sample (con-
taining 8–10 g of total protein depending on each particular run) were
loaded in each well, and increasing amounts of protein pooled from the
samples were also loaded and electrophoresed to produce a standard
curve. Proteins were transferred electrophoretically to polyvinylidene
fluoride Immobilon-Pmembranes (Millipore, Bedford,MA) at 0.3 A for
4 h. Membranes were washed four times for 15 min in blocking buffer:
2% polyvinylpyrrolidone in PBST (phosphate-buffered saline plus
0.05% Tween 20, pH 7.4) for phospho-ERK1/2 and phospho-GluR1 or
2% nonfat dry milk in PBST for total ERK1/2 and total GluR1. Mem-
branes were then incubated overnight at 4°Cwith their primary antibody
diluted in the respective blocking buffers plus 0.01% sodium azide. The
antibodies used were rabbit polyclonal anti-GluR1 (1:2000 dilution;
Chemicon, Temecula, CA), rabbit polyclonal anti-phospho-Ser845
GluR1 (1:2000 dilution; Upstate, Charlottesville, VA), rabbit polyclonal
anti-ERK1/2 (1:2000 dilution; Cell Signaling Technology), and rabbit
polyclonal anti-phospho-Thr202/Tyr204 ERK1/2 (1:5000 dilution; Cell
Signaling Technology). After four washes for 15 min in blocking buffer,
the blots were incubated for 2 h at room temperature with horseradish
peroxidase-conjugated secondary goat anti-rabbit IgG antibody in
blocking buffer (1:2000 dilution, PI-1000; Vector Laboratories). Finally,
the blots were washed six times for 10 min in PBS and incubated during
60 s in the reagents of the enhanced chemiluminescence procedure of
Amersham Biosciences (Piscataway, NJ). Luminescence from the blots
was detected by exposing the membranes to Amersham Biosciences Hy-
perfilm during 30 s to 5 min, followed by digital scanning of the devel-
oped film in transparency mode. The scanned image of the membranes
and band intensities were calibrated and quantified using NIH ImageJ
software (version 1.34). The amount of the protein of interest in each
sample was interpolated from the band intensities of the standard curves.
The standard curves run with the Western blots in our assays indicate
that the band intensities for each of the test samples quantified were
within linear range of detection. For each animal, the values obtained
from the experiments with phosphorylated and total ERK1/2 corre-
sponded to the addition of the bands intensities of both ERK1 and ERK2
(also called p44 and p42 MAP kinases, in relation to their molecular
weights, 44 and 42 kDa, respectively). For each animal, the values of
phosphorylated ERK1/2 and phosphorylated GluR1were normalized (as
percentage of control) to total ERK1/2 and total GluR1 subunit of the
AMPA receptor, respectively. In each Western blot, all values were nor-
malized (as percentage of control) with respect to the average of the
values from two vehicle-treated animals included in the same blot.
Results
As reported previously (Sgambato et al., 1998; Gerfen et al.,
2002), cortical stimulation in the orofacial area of the lateral
agranularmotor cortex (demonstrated by the selective elicitation
of jaw movements) induced a predominant phosphorylation of
ERK1/2 in the lateral caudate–putamen at the AP level of bregma
0.0 1.0 mm (Fig. 1). Also as reported previously (Sgambato et
al., 1998), ERK1/2 phosphorylation could also be observed in the
contralateral striatum (data not shown). Western blot assays
were therefore performed from punches of the lateral striatum
corresponding to the area with maximal ERK1/2 phosphoryla-
tion. Cortical stimulation induced a significant 50% increase in
ERK1/2 phosphorylation in the ipsilateral striatum compared
with electrode-implanted nonstimulated controls (Fig. 2). This
effect was significantly counteracted by the nonselective adeno-
sine receptor antagonist caffeine and by the selective A2A receptor
antagonist MSX-3 but not by the A1 receptor antagonist CPT
(Fig. 2). None of the adenosine receptor antagonists produced
any significant effect in sham nonstimulated animals (Fig. 2).
Corticostriatal stimulation was also found to significantly in-
crease phosphorylation of the Ser845 residue of theGluR1 subunit
of the AMPA receptor in the ipsilateral striatum (75% increase
compared with controls) (Fig. 3). Striatal AMPA receptor phos-
phorylation was also completely counteracted by caffeine or
MSX-3, whereas CPT did not significantly modify AMPA recep-
tor phosphorylation induced by cortical stimulation. Again, none
of the adenosine receptor antagonists produced any significant
effect in sham nonstimulated animals (Fig. 3). There were not
significant differences in the values of total ERK1/2 and GluR1
subunit of the AMPA receptors between the different sham and
stimulated groups.
Discussion
It can be assumed that there are two major distinct types of stri-
atal glutamatergic synapses, theD1 receptor-regulated and theD2
(and A2A) receptor-regulated glutamatergic synapses, mostly lo-
calized at the heads of the dendritic spines of the GABAergic
dynorphinergic and GABAergic enkephalinergic neurons, re-
Figure 2. Striatal ERK1/2 phosphorylation induced by cortical electrical stimulation. Caf-
feineand theA2A receptor antagonistMSX-3, butnot theA1 receptor antagonist CPT, counteract
ERK1/2 phosphorylation induced by cortical electrical stimulation. Results are shown in
means SEM (n 6–10 per group) of representative Western blots. *p 0.05 and **p
0.01, significantly different compared with the vehicle (Veh)-treated group; #p 0.05 and
##p  0.01, significantly different compared with the stimulated vehicle-treated group
(VehS) (ANOVA with Tukey–Kramer tests).
Figure 3. Striatal GluR1 phosphorylation induced by cortical electrical stimulation. Caffeine
and the A2A receptor antagonist MSX-3, but not the A1 receptor antagonist CPT, counteract
GluR1phosphorylation inducedby cortical electrical stimulation. Results are shown inmeans
SEM (n 5–13 per group) and representative Western blots. *p 0.05 and ***p 0.001,
significantly different compared with the vehicle (Veh)-treated group; ###p 0.001, signifi-
cantly different compared with the stimulated vehicle-treated group (VehS) (ANOVA with
Tukey–Kramer tests).
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spectively (Ferre´ et al., 2005). Dopamine afferents make prefer-
ential synaptic contact with the neck of the dendritic spines
(Gerfen, 2004). This arrangement allowsmesencephalic dopami-
nergic inputs tomodulate cortico-limbic-thalamic glutamatergic
excitatory inputs. In the GABAergic dynorphinergic neuron, do-
pamine stimulates D1 receptors, whichmodulate neuronal excit-
ability and glutamatergic neurotransmission by inducing PKA-
mediated phosphorylation of different substrates, which include
NMDAandAMPA receptors. PKA-mediated phosphorylation of
NMDA receptors (in the C terminus of the NR1–1 subunit) po-
tentiates NMDA receptor-mediated currents (Greengard et al.,
1999), and there is also evidence for a tight crosstalk between the
second-messenger pathways of D1 and NMDA receptors (Dud-
man et al., 2003). These functional interactions depend on the
existence of physical interactions, heteromerization, between the
D1 receptor and specific subunits of the NMDA receptor (Lee et
al., 2002; Woods and Ferre´, 2005). Coactivation of D1 and
NMDA receptors inducesMAPK activation (Valjent et al., 2005),
although a significant phosphorylation of ERK1/2 can be ob-
tained with selective stimulation of D1 receptors under condi-
tions of chronic dopamine depletion (Gerfen et al., 2002; Kim et
al., 2006). D1 receptor-mediated PKA activation can also induce
phosphorylation at Ser845 of the GluR1 subunit of the AMPA
receptor (Wolf et al., 2003), which, together with phosphoryla-
tion of ERK1/2, are critical initial steps in the establishment of
plastic changes in excitatory synapses, involving recruitment of
AMPA receptors to the postsynaptic density (Malinow and
Malenka, 2002; Lee et al., 2003; Thomas and Huganir, 2004). In
fact, D1 receptor-mediated AMPA receptor phosphorylation (at
Ser845 of theGluR1 subunit) has been shown to be involved in the
dopamine-mediated modulation of glutamate-dependent stria-
tal synaptic plasticity (Wolf et al., 2003).
The D1 receptor-mediated mechanisms by which dopamine
can potentiate the function and plasticity of glutamatergic syn-
apses in the GABAergic dynorphinergic neuron cannot operate
in the D2–A2A receptor-regulated glutamatergic synapse of the
GABAergic enkephalinergic neurons, in which dopamine, by
acting on D2 receptors, inhibits the cAMP–PKA cascade and
MAPK (Ferre´ et al., 1997, 2004, 2005; Gerfen et al., 2002). In the
GABAergic enkephalinergic neurons, it is adenosine, by acting on
A2A receptors, thatmimics the role of dopamine andD1 receptors
on the glutamatergic synapses of GABAergic dynorphinergic
neurons. A2A receptors are more concentrated in the striatum
than anywhere else in the brain, and they are preferentially lo-
cated both presynaptically and postsynaptically at glutamatergic
synapses, in a strategic position to modulate corticostriatal input
to the GABAergic enkephalinergic neurons (Hettinger et al.,
2001; Ciruela et al., 2006). At the postsynaptic site, A2A receptors
form heteromeric complexes with D2 and metabotropic gluta-
mate mGlu5 receptors localized in the perisynaptic ring outside
the synaptic cleft (Ferre´ et al., 2005). Costimulation of A2A and
mGlu5 receptors exerts a synergistic effect on their ability to in-
hibit dopamine binding to the D2 receptor and onMAPK activa-
tion (Popoli et al., 2001; Ferre´ et al., 2002; Nishi et al., 2003). At
the presynaptic site and inside the synaptic cleft, A2A receptors
form heteromeric complexes with adenosine A1 receptors, which
provide a switch mechanism by which low and high concentra-
tions of adenosine inhibit and stimulate, respectively, glutamate
release (Ciruela et al., 2006).
In the GABAergic enkephalinergic neurons, A2A receptor-
mediated PKA activation can potentially phosphorylate the dif-
ferent substrates involved in synaptic plasticity. However, under
basal conditions, endogenous dopamine exerts a strong tonic
activation of D2 receptors in the striatum, which impairs the
ability of A2A receptors to signal through the cAMP–PKA cas-
cade. For instance, A2A receptor blockade does not produce a
decrease in the basal PKA-mediated phosphorylation of GluR1
(at Ser845 of the GluR1 subunit), although it counteracts GluR1
phosphorylation induced byD2 receptor blockade (Hakansson et
al., 2006). We have postulated that a strong cortico-limbic-
thalamic glutamatergic input produces a sufficient amount of
intrasynaptic glutamate and adenosine (most probably derived
from ATP coreleased with glutamate), with a significant stimula-
tion of presynaptic A2A receptors and postsynaptic perisynaptic
A2A and mGlu5 receptors. Then, under conditions of strong glu-
tamatergic input, adenosine and A2A receptors can provide a
mechanism of facilitation of plastic changes in the excitatory syn-
apses of the GABAergic enkephalinergic neurons (Ferre´ et al.,
2005). The present results strongly support this hypothesis, be-
cause phosphorylation of ERK1/2 andGluR1 at Ser845 induced by
stimulation of corticostriatal afferents was completely dependent
on A2A receptor function. The results also indicate that caffeine,
the most consumed psychoactive drug in the world, can poten-
tially alter this form of striatal plasticity, which suggests that caf-
feine may be deleterious for the normal development of striatal
function.
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